Journal article
Left Ventricular Dysfunction Among Patients With Embolic Stroke of Undetermined Source and the Effect of Rivaroxaban vs Aspirin
Abstract
Importance: It is uncertain whether anticoagulation is superior to aspirin at reducing recurrent stroke in patients with recent embolic strokes of undetermined source (ESUS) and left ventricular (LV) dysfunction.
Objective: To determine whether anticoagulation is superior to aspirin in reducing recurrent stroke in patients with ESUS and LV dysfunction.
Authors
Merkler AE; Pearce LA; Kasner SE; Shoamanesh A; Birnbaum LA; Kamel H; Sheth KN; Sharma R
Journal
JAMA Neurology, Vol. 78, No. 12, pp. 1454–1460
Publisher
American Medical Association (AMA)
Publication Date
December 1, 2021
DOI
10.1001/jamaneurol.2021.3828
ISSN
2168-6149